AtriCure (ATRC) Short-term Investments (2010 - 2024)

AtriCure (ATRC) has reported Short-term Investments for 15 consecutive years, with $8.0 million the latest figure, recorded in Q2 2024.

• In Q2 2024, Short-term Investments fell 86.64% year-over-year to $8.0 million; the TTM figure through Jun 2024 stood at $8.0 million (down 86.64% YoY), while the FY2023 annual figure was $53.0 million, down 15.93% from the prior year.
• Short-term Investments retreated to $8.0 million in Q2 2024 per ATRC's latest filing, from $41.0 million in the prior quarter.
• Across five years, Short-term Investments topped out at $202.3 million in Q4 2020 and bottomed at $8.0 million in Q2 2024.
• Historically, Short-term Investments has averaged $85.5 million across 5 years, with a median of $68.9 million in 2022.
• Annual changes were most pronounced in 2020 — Short-term Investments soared 328.91% — and 2024, when it sank 86.64%.
• AtriCure's Short-term Investments stood at $202.3 million in 2020, then sank by 62.71% to $75.4 million in 2021, then retreated by 16.47% to $63.0 million in 2022, then declined by 15.93% to $53.0 million in 2023, then slumped by 84.93% to $8.0 million in 2024.
• Business Quant data shows ATRC's Short-term Investments at $8.0 million in Q2 2024, $41.0 million in Q1 2024, and $53.0 million in Q4 2023.